Search Results 31-40 of 37369 for Two-phase

  1. Phase 2 Study of VGT-309 in Lung Cancer - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  2. Phase 2 Trial of Blinatumomab in Philadelphia Positive/BCR-ABL Positive Acute Lymphoblastic Leukemia - Mayo Clinic

    This is a single-arm Simon II stage design, multicenter study consisting of a screening period, an induction treatment period (2 cycles of blinatumomab), a ...

  3. Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 - Mayo Clinic

    A gene editing medication is one that changes a targeted gene forever. Participation eligibility. Participant eligibility includes age, gender, type and stage ...

  4. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

    This clinical trial is a Phase 1-2, open-label, sequential-group, dose-escalation and cohort-expansion study evaluating the safety, pharmacokinetics, ...

  5. Phase 1/2 Study of AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation - Mayo Clinic

    About this study. Study AG221-C-001 is a Phase 1/2, multicenter, open-label, dose-escalation, safety, PK/PD, and clinical activity evaluation of orally ...

  6. Regular exercise can help you reach a goal weight and stay at it. Phases of the South Beach Diet. The South Beach Diet has three phases: Phase 1. This two-week ...

  7. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects - Mayo Clinic

    The purpose of this two-phase study is to compare CMP-001 intratumoral (IT) and nivolumab intravenous (IV) compared to nivolumab monotherapy administered to ...

  8. Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) - Mayo Clinic

    Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION). Print ...

  9. Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  10. Evanthia Galanis, M.D. - Mayo Clinic Faculty Profiles

    Galanis' practice-changing clinical research includes multiple national phase 2 and randomized phase 2/3 clinical trials of novel therapeutics for primary brain ...